PIKL yields 2000000.00% · JNJ yields 2.13%● Live data
📍 PIKL pulled ahead of the other in Year 1
Combined, PIKL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PIKL + JNJ for your $10,000?
Piksel, Inc. designs, builds, develops, and manages online video solutions. It offers Fuse Metadata Manager, a tool to manage editorial workflows and consolidate their metadata into a single dataset; Fuse Publisher, a solution to bring siloed workflows together and deliver a unified and digital supply chain; Digital Showcase, a product for transition from legacy supply systems to emerging devices, experiences, and trends; Digital Enterprise, an online video platform that enables organisations to distribute and manage their video content in one place; and Piksel Palette, a cloud-native microservices architecture. The company also provides services such as design, development, and implementation; systems integration; support and monitoring; and hosting. Its clientele include Liberty Global, Discovery Channel, Virgin Mobile, United States Courts, Telecom Italia, and American Eagle Foundation. The company partners with Amazon Web Services, Akamai, CDNetworks, harmonic, and Media Excel. Piksel, Inc. was formerly known as KIT digital, Inc. and changed its name to Piksel, Inc. in August 2013. The company was incorporated in 1998 and is headquartered in Atlanta, Georgia.
Full PIKL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.